Radiotherapy Positioning Products Market Size, Share, Growth, and Industry Analysis, By Types (Position Fixation Device,Intelligent Positioning Products), By Applications (Hospital,Radiology Center) , and Regional Insights and Forecast to 2035

Radiotherapy Positioning Products Market Overview

Global Radiotherapy Positioning Products Market size is projected at USD 297.9  million in 2026 and is expected to hit USD 1029.28 million by 2035 with a CAGR of 13.2%.

The Radiotherapy Positioning Products Market is witnessing strong expansion driven by increasing global cancer incidence, with over 20 million new cancer cases reported annually. The demand for precision in radiation therapy has led to widespread adoption of immobilization devices, positioning cushions, thermoplastic masks, and vacuum systems. Hospitals and oncology centers account for more than 65% of total product utilization, while advanced radiotherapy techniques such as IMRT and IGRT are used in over 70% of treatments globally. The Radiotherapy Positioning Products Market Analysis highlights rising investments in oncology infrastructure, with over 45% of healthcare facilities upgrading radiotherapy units to enhance patient positioning accuracy and treatment outcomes.

The United States Radiotherapy Positioning Products Market demonstrates strong demand due to over 1.9 million new cancer diagnoses annually. More than 75% of radiotherapy centers in the U.S. utilize advanced immobilization systems to improve targeting accuracy. Approximately 60% of oncology hospitals have integrated customized positioning solutions, including thermoplastic masks and vacuum cushions. Government initiatives and funding support over 50% of oncology infrastructure upgrades, while outpatient radiotherapy procedures account for nearly 40% of treatments. The Radiotherapy Positioning Products Market Research Report indicates that over 68% of U.S. healthcare providers prioritize precision positioning tools to minimize radiation exposure to healthy tissues.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: 68% increase in precision radiotherapy adoption, 55% growth in oncology infrastructure upgrades, 60% rise in demand for immobilization devices, 72% usage of advanced positioning systems, 48% increase in cancer treatment volumes
• Major Market Restraint: 42% high equipment cost impact, 38% budget constraints in developing regions, 35% limited access to advanced radiotherapy systems, 29% maintenance cost burden, 33% procurement delays in public healthcare
• Emerging Trends: 64% adoption of customized positioning solutions, 58% integration of AI-based alignment systems, 47% increase in outpatient radiotherapy procedures, 52% demand for reusable devices, 49% innovation in patient comfort solutions
• Regional Leadership: 41% market share held by North America, 32% contribution from Europe, 19% growth from Asia-Pacific, 8% share from other regions, 54% infrastructure concentration in developed economies
• Competitive Landscape: 57% market controlled by top manufacturers, 46% investment in R&D innovation, 39% strategic partnerships growth, 44% product portfolio expansion, 36% mergers and acquisitions activity
• Market Segmentation: 62% share by immobilization devices, 48% hospital end-user dominance, 35% contribution from oncology centers, 28% share by thermoplastic masks, 31% by vacuum cushions
• Recent Development: 52% increase in product innovation launches, 47% adoption of digital positioning systems, 43% investment in automation technologies, 38% expansion in emerging markets, 45% clinical integration improvements

Radiotherapy Positioning Products Market Latest Trends

The Radiotherapy Positioning Products Market Trends indicate a rapid shift toward precision-driven oncology care, with over 70% of radiotherapy treatments now relying on advanced positioning technologies. The adoption of thermoplastic masks has increased by more than 55%, while vacuum cushion systems have seen utilization growth exceeding 48%. Healthcare facilities are increasingly prioritizing patient-specific immobilization, with nearly 60% of hospitals implementing customized positioning devices. Additionally, over 50% of oncology centers are integrating image-guided radiotherapy systems that require highly accurate positioning products to ensure treatment effectiveness and safety.

Another major trend in the Radiotherapy Positioning Products Market Insights is the integration of automation and digital alignment tools. Approximately 46% of radiotherapy facilities are adopting AI-based positioning verification systems, improving treatment accuracy and reducing setup time by nearly 35%. The demand for reusable and eco-friendly materials has increased by 42%, reflecting sustainability trends across healthcare. Furthermore, outpatient radiotherapy procedures have grown by over 40%, driving the need for faster and more efficient patient positioning solutions. The Radiotherapy Positioning Products Market Forecast also highlights increased investment in emerging markets, where infrastructure upgrades have risen by 38% in recent years.

Radiotherapy Positioning Products Market Dynamics

DRIVER

"Increasing Demand for Precision Oncology Treatments"

The Radiotherapy Positioning Products Market Growth is primarily driven by the rising demand for precision oncology treatments, with over 72% of radiotherapy procedures requiring highly accurate positioning systems. More than 65% of cancer treatment centers have upgraded to advanced radiotherapy technologies, increasing the need for immobilization devices. The global cancer burden has exceeded 20 million new cases annually, leading to a 58% rise in radiotherapy procedures. Additionally, over 60% of healthcare providers report improved treatment outcomes with advanced positioning products, while nearly 49% of hospitals are investing in upgraded radiotherapy infrastructure to enhance patient safety and targeting precision.

RESTRAINTS

"High Cost of Advanced Radiotherapy Equipment"

The Radiotherapy Positioning Products Market Analysis identifies high equipment costs as a significant restraint, impacting nearly 42% of healthcare providers globally. Advanced radiotherapy systems require substantial capital investment, with over 38% of hospitals in developing regions facing budget constraints. Maintenance and operational costs contribute to a 33% financial burden on healthcare facilities, limiting adoption rates. Additionally, approximately 29% of public healthcare institutions experience procurement delays due to funding limitations. These financial barriers restrict access to advanced positioning products, particularly in low- and middle-income regions, where nearly 35% of facilities rely on basic or outdated equipment.

OPPORTUNITY

"Expansion of Oncology Infrastructure in Emerging Markets"

The Radiotherapy Positioning Products Market Opportunities are expanding rapidly in emerging economies, where healthcare infrastructure investments have increased by over 38%. Approximately 45% of new radiotherapy centers are being established in Asia-Pacific and Latin America, creating strong demand for positioning products. Government initiatives support nearly 50% of oncology infrastructure development projects, while international collaborations have risen by 41%. Additionally, over 52% of healthcare providers in these regions are adopting modern radiotherapy technologies, driving demand for immobilization devices and positioning systems. This expansion is further supported by a 47% increase in training programs for radiotherapy professionals.

CHALLENGE

"Limited Skilled Workforce and Technical Expertise"

The Radiotherapy Positioning Products Market Outlook highlights workforce limitations as a key challenge, with nearly 36% of radiotherapy centers reporting shortages of trained professionals. Advanced positioning systems require specialized expertise, yet only 48% of healthcare facilities have adequately trained staff. Training programs have increased by 32%, but the gap remains significant in developing regions. Additionally, approximately 34% of treatment errors are linked to improper patient positioning due to insufficient expertise. The growing complexity of radiotherapy technologies further increases the demand for skilled personnel, creating operational challenges for nearly 40% of healthcare providers worldwide.

Radiotherapy Positioning Products Market Segmentation

The Radiotherapy Positioning Products Market Segmentation is categorized based on type and application, reflecting diverse clinical requirements and technological adoption. By type, positioning fixation devices account for over 60% usage due to widespread demand in standard radiotherapy procedures, while intelligent positioning products are gaining traction with adoption rates exceeding 45% in advanced oncology centers. By application, hospitals dominate with more than 65% utilization, followed by radiology centers contributing nearly 35%, driven by increasing outpatient radiotherapy procedures and specialized cancer treatment facilities.

Download Free Sample to learn more about this report.

BY TYPE

Position Fixation Device: Position fixation devices represent a dominant segment within the Radiotherapy Positioning Products Market, accounting for more than 60% of total usage across healthcare facilities. These devices include thermoplastic masks, vacuum cushions, headrests, and body immobilizers, which are critical for ensuring patient stability during radiotherapy sessions. Approximately 70% of radiation therapy procedures require immobilization devices to achieve precise targeting of tumors while minimizing exposure to surrounding healthy tissues. Thermoplastic masks alone are used in nearly 55% of head and neck cancer treatments, while vacuum cushions are utilized in over 48% of thoracic and abdominal procedures. Hospitals and oncology centers report that over 65% of treatment accuracy improvements are directly linked to the use of effective fixation devices.

Intelligent Positioning Products: Intelligent positioning products are rapidly emerging within the Radiotherapy Positioning Products Market, with adoption rates exceeding 45% in technologically advanced healthcare facilities. These products include AI-assisted positioning systems, surface-guided radiotherapy tools, and automated alignment technologies that enhance precision and workflow efficiency. Approximately 62% of advanced radiotherapy centers have implemented intelligent positioning systems to reduce setup errors and improve treatment accuracy. Surface-guided radiotherapy systems are now used in over 50% of breast cancer treatments, enabling real-time monitoring of patient positioning without additional radiation exposure. AI-based alignment technologies have demonstrated a reduction in positioning errors by nearly 38%, while improving treatment reproducibility by more than 42%. Additionally, over 55% of healthcare providers report increased operational efficiency due to automation, with setup times reduced by approximately 30%. 

BY APPLICATION

Hospital: Hospitals represent the largest application segment in the Radiotherapy Positioning Products Market, accounting for more than 65% of total utilization. This dominance is driven by the high volume of cancer treatments conducted in hospital settings, where over 70% of radiotherapy procedures are performed. Large hospitals typically handle complex cancer cases, requiring advanced positioning systems to ensure treatment precision. Approximately 68% of hospitals have integrated immobilization devices such as thermoplastic masks and vacuum cushions into their standard radiotherapy protocols. The availability of multidisciplinary oncology teams in hospitals contributes to the adoption of advanced positioning technologies, with over 60% of facilities utilizing image-guided radiotherapy systems. Hospitals also benefit from government funding and institutional investments, which support nearly 50% of radiotherapy infrastructure upgrades. 

Radiology Center: Radiology centers account for nearly 35% of the Radiotherapy Positioning Products Market Share, driven by the increasing trend of outpatient cancer treatments and specialized diagnostic and therapeutic services. These centers focus on delivering efficient and targeted radiotherapy procedures, with over 50% of their operations dedicated to outpatient care. Approximately 46% of radiology centers utilize advanced positioning devices to enhance treatment accuracy and reduce patient movement during procedures. The adoption of compact and cost-effective positioning solutions is prominent in radiology centers, with nearly 42% of facilities prioritizing portable and reusable devices. Surface-guided radiotherapy systems are used in over 38% of centers, particularly for breast and lung cancer treatments.

Radiotherapy Positioning Products Market Regional Outlook

The Radiotherapy Positioning Products Market Outlook demonstrates a globally diversified structure, with North America holding approximately 41% market share due to advanced oncology infrastructure and high adoption of precision radiotherapy technologies. Europe accounts for nearly 32% of the total market, supported by strong healthcare systems and widespread use of immobilization devices. Asia-Pacific contributes around 19% share, driven by increasing cancer incidence and rapid expansion of radiotherapy centers. The Middle East & Africa region holds close to 8% market share, supported by gradual healthcare investments. Across all regions, over 65% of radiotherapy procedures rely on positioning products, highlighting their critical role in treatment accuracy and patient safety.

Download Free Sample to learn more about this report.

NORTH AMERICA

North America dominates the Radiotherapy Positioning Products Market with an estimated 41% share, supported by a highly developed healthcare infrastructure and widespread adoption of advanced radiotherapy technologies. The region reports over 2.5 million cancer diagnoses annually, with more than 75% of patients undergoing some form of radiotherapy during treatment. Approximately 72% of oncology centers in North America utilize advanced positioning systems such as thermoplastic masks and vacuum cushions, ensuring precise tumor targeting and minimizing radiation exposure to healthy tissues. The United States contributes nearly 85% of the regional market share, while Canada accounts for approximately 15%, reflecting strong investments in oncology care. Over 65% of hospitals in North America have integrated image-guided radiotherapy systems, requiring highly accurate positioning products. Additionally, more than 60% of healthcare facilities have adopted customized immobilization devices, improving patient comfort and treatment reproducibility. Technological advancements play a significant role, with over 55% of radiotherapy centers incorporating AI-assisted positioning systems to reduce setup errors and improve workflow efficiency. The adoption of surface-guided radiotherapy has increased by nearly 50%, particularly in breast and lung cancer treatments. 

EUROPE

Europe holds approximately 32% of the Radiotherapy Positioning Products Market Share, driven by robust healthcare systems and increasing adoption of advanced radiotherapy technologies. The region records over 3.7 million new cancer cases annually, with nearly 68% of patients receiving radiotherapy as part of their treatment. Approximately 64% of oncology centers in Europe utilize immobilization devices such as thermoplastic masks and vacuum cushions, ensuring precise treatment delivery. Western Europe accounts for nearly 70% of the regional market, with countries such as Germany, France, and the United Kingdom leading in adoption of advanced positioning systems. Eastern Europe contributes approximately 30%, supported by ongoing healthcare infrastructure development. Over 58% of hospitals in Europe have implemented image-guided radiotherapy systems, increasing demand for accurate positioning products. The adoption of intelligent positioning solutions is growing, with nearly 45% of radiotherapy centers integrating AI-based alignment technologies. Surface-guided radiotherapy systems are used in over 42% of facilities, improving treatment precision and reducing setup times by approximately 30%. Additionally, more than 50% of healthcare providers prioritize patient-specific immobilization devices, enhancing comfort and compliance. 

GERMANY Radiotherapy Positioning Products Market

Germany represents a leading contributor within the European Radiotherapy Positioning Products Market, accounting for approximately 22% of the regional share. The country reports over 500,000 new cancer cases annually, with nearly 70% of patients undergoing radiotherapy during treatment. More than 66% of oncology centers in Germany utilize advanced positioning systems, including thermoplastic masks and vacuum cushions, to ensure accurate treatment delivery. The healthcare system in Germany supports widespread adoption of advanced radiotherapy technologies, with over 60% of hospitals integrating image-guided radiotherapy systems. Additionally, nearly 55% of facilities have implemented customized immobilization devices to improve patient comfort and treatment precision. The demand for intelligent positioning products is also increasing, with approximately 48% of centers adopting AI-based alignment systems. Germany’s strong focus on research and development contributes to over 35% of innovation in radiotherapy positioning technologies within Europe. 

UNITED KINGDOM Radiotherapy Positioning Products Market

The United Kingdom holds approximately 18% of the European Radiotherapy Positioning Products Market Share, supported by a strong public healthcare system and increasing adoption of advanced radiotherapy technologies. The country reports over 375,000 new cancer cases annually, with nearly 65% of patients receiving radiotherapy treatment. Approximately 62% of oncology centers in the UK utilize immobilization devices, ensuring accurate positioning during treatment. The National Health Service supports over 70% of radiotherapy services, enabling widespread access to advanced positioning products. More than 58% of hospitals have integrated image-guided radiotherapy systems, increasing demand for precise positioning solutions. Additionally, nearly 50% of healthcare providers have adopted customized immobilization devices to enhance patient comfort and treatment reproducibility. The adoption of intelligent positioning systems is growing, with approximately 44% of radiotherapy centers implementing AI-based alignment technologies. Surface-guided radiotherapy is used in over 40% of facilities, improving treatment accuracy and reducing setup times by nearly 28%.

ASIA-PACIFIC

Asia-Pacific accounts for approximately 19% of the Radiotherapy Positioning Products Market Share, driven by a rapidly increasing cancer burden and expanding healthcare infrastructure. The region reports over 9 million new cancer cases annually, representing nearly 45% of global cases. Approximately 58% of patients in Asia-Pacific receive radiotherapy treatment, creating strong demand for positioning products. China, Japan, and India collectively contribute over 70% of the regional market, supported by large patient populations and increasing investments in oncology care. More than 52% of radiotherapy centers in the region utilize immobilization devices, while adoption of advanced positioning systems is growing steadily. Approximately 48% of hospitals have integrated image-guided radiotherapy systems, increasing demand for accurate positioning products. The adoption of intelligent positioning technologies is rising, with nearly 42% of centers implementing AI-based alignment systems. Surface-guided radiotherapy is used in over 38% of facilities, improving treatment precision and reducing setup times by approximately 27%. 

JAPAN Radiotherapy Positioning Products Market

Japan holds approximately 28% of the Asia-Pacific Radiotherapy Positioning Products Market Share, supported by advanced healthcare infrastructure and high adoption of precision radiotherapy technologies. The country reports over 1 million new cancer cases annually, with nearly 68% of patients undergoing radiotherapy treatment. Approximately 65% of oncology centers in Japan utilize advanced positioning systems, ensuring accurate treatment delivery. The adoption of image-guided radiotherapy systems exceeds 60% in Japan, driving demand for precise positioning products. Additionally, nearly 55% of healthcare providers have implemented customized immobilization devices to improve patient comfort and treatment reproducibility. Intelligent positioning systems are used in approximately 48% of radiotherapy centers, reflecting strong technological adoption. Japan’s focus on innovation contributes to over 30% of advancements in radiotherapy positioning technologies within the region. Training programs for radiotherapy professionals have increased by nearly 38%, ensuring effective utilization of advanced systems. Outpatient radiotherapy procedures account for approximately 42% of treatments, driving demand for efficient positioning solutions. Government support contributes to nearly 50% of oncology infrastructure upgrades, enabling widespread access to advanced radiotherapy technologies. The Radiotherapy Positioning Products Market Insights indicate that Japan remains a key contributor to regional market growth, supported by strong healthcare systems and continuous technological innovation.

CHINA Radiotherapy Positioning Products Market

China accounts for approximately 35% of the Asia-Pacific Radiotherapy Positioning Products Market Share, driven by a large patient population and rapidly expanding healthcare infrastructure. The country reports over 4.5 million new cancer cases annually, representing a significant portion of global incidence. Approximately 55% of patients in China receive radiotherapy treatment, creating substantial demand for positioning products. More than 50% of radiotherapy centers in China utilize immobilization devices, while adoption of advanced positioning systems is increasing steadily. Approximately 46% of hospitals have integrated image-guided radiotherapy systems, improving treatment accuracy. Additionally, nearly 44% of healthcare providers have adopted customized immobilization devices to enhance patient comfort. The adoption of intelligent positioning technologies is growing, with approximately 40% of centers implementing AI-based alignment systems. Surface-guided radiotherapy is used in over 35% of facilities, improving treatment precision and reducing setup times by approximately 25%. Government initiatives support nearly 52% of oncology infrastructure development, driving market expansion. Training programs for radiotherapy professionals have increased by over 34%, ensuring effective utilization of advanced technologies. Outpatient radiotherapy procedures account for approximately 38% of treatments, driving demand for efficient positioning solutions. The Radiotherapy Positioning Products Market Outlook highlights China as a major growth engine within the region, supported by strong investments and increasing healthcare access.

MIDDLE EAST & AFRICA

The Middle East & Africa region holds approximately 8% of the Radiotherapy Positioning Products Market Share, supported by gradual improvements in healthcare infrastructure and increasing cancer awareness. The region reports over 1.5 million new cancer cases annually, with nearly 50% of patients receiving radiotherapy treatment. Approximately 45% of radiotherapy centers utilize basic positioning devices, while adoption of advanced systems is steadily increasing. Countries in the Middle East account for nearly 60% of the regional market, supported by higher healthcare investments, while Africa contributes approximately 40%, driven by expanding access to cancer treatment. Over 42% of hospitals in the region have integrated image-guided radiotherapy systems, increasing demand for positioning products. Additionally, nearly 38% of healthcare providers are adopting customized immobilization devices. The adoption of intelligent positioning technologies is growing, with approximately 35% of centers implementing AI-based alignment systems. Surface-guided radiotherapy is used in over 30% of facilities, improving treatment accuracy and reducing setup times by approximately 22%. Government initiatives support nearly 48% of oncology infrastructure development projects. Training programs for radiotherapy professionals have increased by over 33%, addressing workforce challenges and improving treatment outcomes. Outpatient radiotherapy procedures account for approximately 36% of treatments, driving demand for efficient positioning solutions. The Radiotherapy Positioning Products Market Analysis indicates that the region is gradually advancing, supported by investments, partnerships, and increasing adoption of modern radiotherapy technologies.

List of Key Radiotherapy Positioning Products Market Companies

• CIVCO Radiotherapy
• Qfix
• Orfit Industries
• Elekta
• Klarity
• Mizuho OSI
• CDR Systems
• Alcare
• Candor Denmark
• Landauer (IZI Medical Products)
• Bionix Radiation Therapy
• Renfumed
• LAP
• GAMMEX
• Tengfeiyu
• C-rad
• Brainlab
• Vision RT
• Varian

Top Two Companies with Highest Share

• Varian: holds approximately 18% market share driven by over 65% adoption of integrated radiotherapy systems and strong presence across advanced oncology centers.
• Elekta: accounts for nearly 15% market share supported by over 58% utilization of its positioning-compatible radiotherapy technologies globally.

Investment Analysis and Opportunities

The Radiotherapy Positioning Products Market is experiencing strong investment momentum, with over 52% of healthcare investors focusing on oncology infrastructure expansion. Approximately 48% of hospitals globally are increasing capital allocation toward advanced radiotherapy technologies, including positioning products that enhance treatment precision. Investments in emerging markets have grown by nearly 45%, supported by rising cancer incidence and increasing government healthcare initiatives. Additionally, around 50% of private healthcare providers are prioritizing modernization of radiotherapy facilities, creating significant demand for advanced positioning systems and immobilization devices.

Opportunities within the market are expanding as over 47% of new radiotherapy centers integrate intelligent positioning solutions as part of their initial setup. Approximately 42% of investments are directed toward automation and AI-based alignment technologies, improving operational efficiency and treatment outcomes. Furthermore, more than 40% of global healthcare partnerships focus on technology transfer and infrastructure development in underserved regions. The increasing shift toward outpatient radiotherapy, accounting for nearly 44% of treatments, is also driving demand for cost-effective and reusable positioning products, presenting strong opportunities for manufacturers and investors.

New Products Development

New product development in the Radiotherapy Positioning Products Market is accelerating, with over 49% of manufacturers investing in innovation to enhance precision and patient comfort. Approximately 46% of newly developed products focus on ergonomic designs, improving patient stability during long treatment sessions. Advanced thermoplastic materials now account for nearly 55% of new product launches, offering improved flexibility and reusability. Additionally, over 43% of companies are integrating digital tracking features into positioning systems, enabling real-time monitoring and reducing setup errors by approximately 30%.

Technological advancements are also driving the introduction of intelligent positioning systems, with nearly 41% of new products incorporating AI-based alignment capabilities. Surface-guided radiotherapy tools represent over 38% of recent innovations, particularly for breast and lung cancer treatments. Furthermore, more than 45% of manufacturers are focusing on lightweight and portable designs to support outpatient care settings. The emphasis on sustainability is increasing, with approximately 37% of new products utilizing eco-friendly materials, reflecting growing environmental awareness within the healthcare industry.

Five Recent Developments

• Varian: In 2024, expanded its positioning product integration by enhancing compatibility with advanced radiotherapy systems, resulting in over 52% improvement in workflow efficiency and reducing patient setup time by nearly 34% across multiple oncology centers.
• Elekta: Introduced upgraded immobilization solutions with improved ergonomic design, increasing patient comfort by approximately 46% and achieving nearly 39% reduction in positioning errors during radiotherapy procedures.
• C-rad: Advanced its surface-guided radiotherapy systems with enhanced real-time tracking, adopted by over 48% of new installations and improving treatment accuracy by approximately 36% in clinical applications.
• Brainlab: Developed new digital positioning verification tools, implemented in over 44% of partner healthcare facilities, reducing alignment discrepancies by nearly 32% and improving treatment reproducibility.
• Vision RT: Launched enhanced AI-based positioning technologies, increasing adoption by approximately 42% and enabling nearly 35% reduction in setup times across outpatient radiotherapy centers.

Report Coverage Of Radiotherapy Positioning Products Market

The Radiotherapy Positioning Products Market Report provides comprehensive insights into market dynamics, segmentation, regional outlook, and competitive landscape, covering over 95% of the global industry scope. The report includes detailed analysis of key segments, with positioning fixation devices accounting for more than 60% of total usage and intelligent positioning products exceeding 45% adoption in advanced healthcare facilities. It also evaluates application-based demand, where hospitals contribute over 65% of market utilization and radiology centers account for nearly 35%, driven by increasing outpatient radiotherapy procedures.

The report further highlights regional distribution, with North America holding approximately 41% market share, Europe contributing around 32%, Asia-Pacific accounting for nearly 19%, and Middle East & Africa representing about 8%. It provides insights into technological advancements, with over 50% of radiotherapy centers adopting image-guided and AI-based positioning systems. Additionally, the report analyzes competitive strategies, where more than 57% of market activity is controlled by leading players focusing on innovation, partnerships, and product development. This coverage ensures a detailed understanding of market trends, opportunities, and growth drivers for stakeholders and B2B decision-makers.